| Serial Number | 97886578 |
| Word Mark | AGENUS |
| Filing Date | Thursday, April 13, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, August 7, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceuticals; therapeutics; biologics for medical purposes; monoclonal antibodies for medical purposes; antibodies for medical purposes; adjuvants for medical purposes; vaccines; cell therapy; cells for medical or clinical use; pharmaceutical preparations and products for the treatment of disease; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease |
| Goods and Services | Biologics for scientific or research purposes; monoclonal antibodies for scientific or research purposes; antibodies for scientific or research purposes |
| Goods and Services | Pharmaceutical research and development; scientific research and development; medical research and development; pharmaceutical research and development in the fields of cancer, immunology, and immuno-oncology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 7, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | Tuesday, May 31, 2016 |
| First Use In Commerce Date | Tuesday, May 31, 2016 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 7, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, May 31, 2016 |
| First Use In Commerce Date | Tuesday, May 31, 2016 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 7, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 6, 2011 |
| First Use In Commerce Date | Thursday, January 6, 2011 |
| Party Name | Agenus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Sunday, August 13, 2023 | ASSIGNED TO EXAMINER |
| Monday, May 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 17, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, August 17, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, August 17, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 15, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, November 15, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, February 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 7, 2024 | ASSIGNED TO LIE |